Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Global Regulatory Systems01:28

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi.

The Journal of protozoologyยท1972
See all related articles

Related Experiment Videos

Endocannabinoid system and cardiometabolic risk.

L E Saavedra1

  • 1General Cardiology & Coronary Care Unit Services, CCR ASCARDIO, Barquisimeto, Venezuela. leonardosaavedra@intercable.net.ve

Clinical Pharmacology and Therapeutics
|September 28, 2007
PubMed
Summary

Obesity worsens cardiovascular disease prevention efforts. Blocking cannabinoid receptors (CB1) may improve fat distribution, insulin sensitivity, and blood lipids, thus reducing cardiometabolic risk.

Area of Science:

  • Metabolic research
  • Cardiovascular disease prevention
  • Endocrinology

Background:

  • Rising overweight and obesity rates impede cardiovascular disease (CVD) prevention progress.
  • Obesity is linked to increased risks of CVDs and diabetes mellitus, termed cardiometabolic risk.
  • The endocannabinoid system's role in energy metabolism is gaining attention.

Purpose of the Study:

  • To explore the potential of blocking cannabinoid receptors (CB1) in managing cardiometabolic risk.
  • To investigate how CB1 blockade might influence fat distribution, insulin sensitivity, and blood lipids.

Main Methods:

  • Review of current research on the endocannabinoid system and metabolic regulation.
  • Analysis of potential therapeutic strategies targeting CB1 receptors for metabolic disorders.

Related Experiment Videos

Main Results:

  • Evidence suggests CB1 receptor blockade may positively impact fat distribution.
  • Potential for improved insulin sensitivity and blood lipid profiles through CB1 antagonism.
  • Targeting CB1 receptors could offer a novel approach to mitigate cardiometabolic risk.

Conclusions:

  • CB1 receptor blockade presents a promising avenue for improving cardiovascular risk profiles in overweight and obese individuals.
  • Further research is warranted to elucidate the full therapeutic potential of CB1 antagonists in metabolic health.